Advarra is a provider of institutional review board (IRB), institutional biosafety committee (IBC), and other research compliance services in North America. Advarra leverages its strengths in technology, regulatory expertise, and customer service to serve the increasingly complex needs associated with research. In November 2017, Chesapeake IRB and Schulman IRB merged to create Advarra.
Investments
Headquarters
Columbia, Maryland
Sector
Pharmaceutical Services
With Linden Since
December 2015 (reinvested in 2019 & 2022)